Pharmacy News

Weekly insulin found safe, effective for T2D

New research published in JAMA shows that once-weekly insulin icodec is safe for people with T2D. It also showed that individuals with T2D who used insulin icodec maintained healthier blood glucose levels compared with people who received daily injections of insulin degludec.

Researchers highlight ‘vital role’ of community pharmacists in public health

Community pharmacies in the United States “played a vital role in the public health response to the COVID-19 pandemic,” said a new commentary published June 29, 2023, in JAMA Forum.

Almost one-half of Americans would spend $100 a month for weight loss drugs

Nearly one-half of Americans said they would be willing to spend up to $100 a month for new weight loss medicines such as semaglutide (Wegovy—Novo Nordisk), and one-third said they would indefinitely pay whatever they can afford to get the drugs, according to a new survey by STAT and Harris Poll.

Diabetes will be ‘a defining disease of this century,’ global cases set to exceed 1 billion by 2050

The prevalence of diabetes is expected to more than double by 2050, according to a new Lancetstudy. Approximately 1 in 10 people worldwide at that time will have diabetes, marking a 60% increase in the prevalence of the disease, said the study findings.

E-cigarette sales climb, according to new report

Sales of e-cigarettes increased by almost 50% from 2020 to 2022, according to a report published in CDC’s Morbidity and Mortality Weekly Report. The report also found that after January 2020, sales of mint- and other-flavored prefilled cartridges died down, and disposable e-cigarettes in fruit, sweet, and other flavors increased. Disposable e-cigarettes in youth-appealing flavors are now more commonly sold than prefilled units.